QIAGEN has revealed the first system of a novel modular platform designed to offer laboratories a new level of flexibility, convenience and safety.
The QIA Symphony SP is the first in a series of modular instruments to be used within a broad range of molecular sample and assay applications.
According to QIAGEN, it can be integrated to automate entire workflows- from sample to result- and can be used to meet laboratory's applied testing, pharmaceutical and life science research needs.
The QIA Symphony SP allows users to load many types of samples in a variety of formats and then isolate, purify and prepare target analytes for further analysis- something which is often viewed as the most challenging step in molecular analysis.
Peer Schatz, chief executive officer of QIAGEN, said: "We are very excited to unveil our QIA Symphony platform and with it the first module: QIA Symphony SP. Standardization and process safety are key for today's labs."
"Cutting-edge technologies, innovative functions and proven QIAGEN chemistries make the QIA Symphony a truly unique solution and create a strong basis for further expansion of our already broad and leading offering of automated sample and assay technologies," he continued.
QIAGEN is a leading provider of sample and assay technologies, providing more than 500 products and technologies use to isolate DNA, RNA and proteins from any biological samples.